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Abstract
Background: Systemic lupus Erythematosus is a chronic autodestructive disease, with loss of
immune tolerance to nucleic acid and other cross reactive antigens. Despite of the numerous
studies, the presence of some new manifestations indicates the greater proportion of unknown
data.
Case presentation: Our case, is a 26-year-old female, by the chief complaint of headache,
vomiting, fever and arthralgia. Some hemorrhagic ulcers in her mouth with fulminant pethechia/
purpura on her limbs and buttocks were prominent. On admission, she was in hypotensive state.
By the clinical suspicion to meningococcal septicemia, lumbar puncture was performed, and
antibiotic therapy was started. Cerebrospinal fluid was normal. Suddenly, on the 3rd day of
admission, hemorrhagic bullae were evolved from those purpuric lesions. Leukocytosis, immune
hemolytic anemia, thrombocytopenia and high antinuclear antibody/double stranded DNA level
and hypocomplemania were present simultaneously. In skin biopsy, immune complex deposition in
dermoepidermal junction was seen. The diagnosis of Systemic lupus Erythematosus was made. The
patient responded well to corticosteroid therapy.
Conclusion: Coetaneous manifestations are very common in Systemic lupus Erythematosus, and
help the physician making differential diagnoses and proper diagnosis. The rapidly evolving
hemorrhagic bulla from primary purpuric lesions, with rapid response to Prednisolone, is a rare
manifestation of Systemic lupus Erythematosus, which should be considered in such a disease
setting.
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Background
Systemic lupus Erythematosus (SLE) is an autodestructive
disease [1], in which loss of immune tolerance to nucleic
acid antigens and other cross reactive antigens has a fun-
damental role [2]. Despite of the numerous studies, the
presence of some new manifestations indicates the greater
proportion of unknown data.
Case presentation
The patient was a 26-year-old female, who referred to our
center, Infectious disease, Alzahra Hospital, Isfahan, Iran,
by the chief complaint of headache, vomiting and fever
from the day before admission. She also was complaining
from arthralgia in wrists and knees, accompanied with
generalized pain. Also, some hemorrhagic ulcers in her
mouth and fulminant pethechia/purpura on her limbs
and buttocks were prominent (Figure 1). On admission,
she was in hypotensive state with some degree of agita-
tion. A mild periorbital edema was also present. So, she
was hospitalized by the clinical suspicion to meningococ-
cal septicemia. Injection of Ceftriaxon plus Vancomycin
was started empirically, and lumbar puncture (LP) per-
formed. Despite of the normal CSF, antibiotics therapy
was continued, up to getting the results of blood culture,
ready. Suddenly, on the 3rd day of antibiotic therapy, hem-
orrhagic bullae were evolved from those purpuric lesions
(Figure 2). These bullae were extending beyond the previ-
ous margins. Due to the negative cultures from blood and
bulla contents, antibiotics were discontinued.
The positive findings in lab data and paraclinical exami-
nation were as follow: Leukocytosis (WBC: 20100/μl),
immune hemolytic anemia (Hb: 7 g/dl) plus positive
direct Coobms test, thrombocytopenia (platelet: 53000/ μl) and high ANA/dSDNA level. C3 and C4 level were 42
(normal range: 55–170) and 12 (normal range: 10–55),
both in low levels. 3 omg/dl protein was present in the
derived urine sample. Skin biopsy demonstrated some
epidermal necrosis, basal layer degeneration, leukocyto-
clasis, dermal neutrophil infiltration, RBC extravasation
plus immune complex deposition in dermoepidermal
junction. By rheumatologic consultation, the diagnosis of
SLE was made (fulfilling 4 criteria of 11). Cellcept was pre-
scribed for the patient; in combination with 60 mg of
daily Prednisolone. After beginning of the treatment the
skin lesions was controlled but convert to disseminated
necrosis. By gradual disappearance of acute phase of the
disease, Anti-dSDNA and ANA were tested again, which
was as high as the first checking.
Discussion
SLE, inflammatory chronic diseases [3], with unknown
etiology, is a prototype of auto immune diseases [4]. It
may affect a number of organ systems in the body, in
which joints, skin, kidneys and lungs are the most com-
mon involved sites [5]. Among these manifestations, skin
Fulminant pethechia/purpura on the limbs in the first day of  admission Figure 1
Fulminant pethechia/purpura on the limbs in the first 
day of admission.
Hemorrhagic bullae on the 3rd day of antibiotic therapy Figure 2
Hemorrhagic bullae on the 3rd day of antibiotic ther-
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lesions; poses a broad spectrum, usually at the active
phase of disease [6] and a great interest in understanding
the probable role of DNA participation, is evolved todays
[7]. These skin manifestations have great diagnostic role
in the diagnosis of SLE. Some of these reported manifesta-
tions are malar rashes [8], erythematous lesions [9], dis-
coid lesions [9], non-scarring alopecia [10] and so on. But
what's the importance of paying attention to these coeta-
neous manifestations? It's well known that improved
diagnosis and treatment of SLE resulted in significant dec-
rement of morbidity from SLE. To widen the demarcated
line between alive or dead cases, a great clinical suspicion,
is needed, especially on coetaneous manifestations,
because of their broad spectrum and being early detecta-
ble by vision. There are also some rare coetaneous mani-
festations beyond the domains of physician's experience
and reports. So, attention to the rare manifestations aside
with the clinical and paraclinical data, afford us the
increased sensitivity in the diagnosis of complicated cases
with difficult diagnosis and resistant to treatment due to
the wrong diagnosis.
Our case is also an interesting one with rapidly evolving
skin lesions, from diffused purpuric lesions to hemor-
rhagic bullae. It's clear that this kind of rapidly evolving
purpuric lesions to massive hemorrhagic bullae can only
be seen in purpura fulminance and DIC [11], but our case
was not a case of DIC. These evolving lesions had a good
response to oral Prednisolone, besides of the normal PT/
PTT/INR values accompanied with immune hemolytic
anemia and thrombocytopenia. So, it seems that purpuric
lesions with progression toward hemorrhagic bullae can
be seen within the natural course of SLE. In the setting of
mentioned skin lesions, SLE should be considered as a dif-
ferential diagnosis, it may help the physician requesting
proper paraclinical tests for proper diagnosis and treat-
ment.
Conclusion
Coetaneous manifestations are very common in SLE, and
help the physician making differential diagnoses and
proper diagnosis. The rapidly evolving hemorrhagic bulla
from primary purpuric lesions, with rapid response to
Prednisolone, is a rare manifestation of SLE, which should
be considered in such a disease setting.
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